Denali Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,200
Closed -$177K 418
2022
Q3
$177K Buy
+5,200
New +$177K 0.08% 142